title: Capecitabine Induced Multifocal Leukoencephalopathy: Do We Have Always to Switch off the Chemotherapy?
abstract: Capecitabine is a well tolerated and safe 5-fluorouracil agent for adjuvant, neoadjuvant chemotherapy or metastatic cases. Neurological side effects require discontinuation of chemotherapy. We report this unique case of a 50-year-old female, who presented an isolated episode of dysarthria and ataxia under bevacizumab, capecitabine, and oxaliplatin treatment due to reversible multifocal leukoencephalopathy that did not recur after readministration of chemotherapy.
authors.affiliation: 1st Department of Neurology, National and Kapodistrian University of Athens Medical School, Eginition Hospital, 74 Vasilissis Sophias Avenue, 11528 Athens, Greece.
authors.forename: Anastasia
authors.initials: A
authors.lastname: Bougea
authors.affiliation: 1st Department of Neurology, National and Kapodistrian University of Athens Medical School, Eginition Hospital, 74 Vasilissis Sophias Avenue, 11528 Athens, Greece.
authors.forename: Panagiota
authors.initials: P
authors.lastname: Voskou
authors.affiliation: 1st Department of Neurology, National and Kapodistrian University of Athens Medical School, Eginition Hospital, 74 Vasilissis Sophias Avenue, 11528 Athens, Greece.
authors.forename: Constantinos
authors.initials: C
authors.lastname: Kilidireas
authors.affiliation: 1st Department of Neurology, National and Kapodistrian University of Athens Medical School, Eginition Hospital, 74 Vasilissis Sophias Avenue, 11528 Athens, Greece.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Andreadou